Literature DB >> 25651871

MicroRNA-155 Deficiency Suppresses Th17 Cell Differentiation and Improves Locomotor Recovery after Spinal Cord Injury.

J Yi1, D Wang, X Niu, J Hu, Y Zhou, Z Li.   

Abstract

Spinal cord injury (SCI) is considered to be primarily associated with loss of motor function and leads to activate diverse cellular mechanisms in the central nervous system to attempt to repair the damaged spinal cord tissue. Mir-155 has been reported to be involved in both innate and adaptive immune responses. But the role of Mir-155 in spinal cord injury is still unknown. In our current study, Mir-155 deficiency displays increased myelin sparring and enhanced SC repair process. The number of T cells, B cells and neutrophils are all significantly lower in Mir-155(-/-) group than that in WT group after SCI. IL-17A-producing cells and the expression of IL-17A are markedly lower in Mir-155(-/-) mice than that in WT mice. We also found higher production of IL-17 by WT CD4(+) T cells than Mir-155(-/-) CD4(+) T cells in vitro. In our further DC-T cell coculture system, Mir-155 deficiency in DCs results in significantly less IL-17 production from T cells. Furthermore, the inhibited Th17 differentiation induced by Mir-155 deficiency is partly dependent on increased expression of SOCS1. In conclusion, our present work provides evidence to support the concept that Mir-155 deficiency suppresses Th17 cell differentiation and improves locomotor recovery after SCI.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25651871     DOI: 10.1111/sji.12276

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

Review 1.  Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?

Authors:  John Bianco; Pauline De Berdt; Ronald Deumens; Anne des Rieux
Journal:  Cell Mol Life Sci       Date:  2016-01-14       Impact factor: 9.261

Review 2.  Biomarkers in Spinal Cord Injury: from Prognosis to Treatment.

Authors:  Leonardo Fonseca Rodrigues; Vivaldo Moura-Neto; Tania Cristina Leite de Sampaio E Spohr
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

3.  Engrafted peripheral blood-derived mesenchymal stem cells promote locomotive recovery in adult rats after spinal cord injury.

Authors:  Qiang Fu; Yi Liu; Xiu Liu; Qian Zhang; Long Chen; Jiachen Peng; Jun Ao; Yuwan Li; Shengmin Wang; Gongyu Song; Limei Yu; Jinwei Liu; Tao Zhang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

Review 4.  Roles of the miR-155 in Neuroinflammation and Neurological Disorders: A Potent Biological and Therapeutic Target.

Authors:  Seyed Hamidreza Rastegar-Moghaddam; Alireza Ebrahimzadeh-Bideskan; Sara Shahba; Amir Mohammad Malvandi; Abbas Mohammadipour
Journal:  Cell Mol Neurobiol       Date:  2022-02-02       Impact factor: 5.046

Review 5.  The Role of microRNA Markers in the Diagnosis, Treatment, and Outcome Prediction of Spinal Cord Injury.

Authors:  Nikolay L Martirosyan; Alessandro Carotenuto; Arpan A Patel; M Yashar S Kalani; Kaan Yagmurlu; G Michael Lemole; Mark C Preul; Nicholas Theodore
Journal:  Front Surg       Date:  2016-11-08

Review 6.  Silencing a Multifunctional microRNA Is Beneficial for Stroke Recovery.

Authors:  Tamara Roitbak
Journal:  Front Mol Neurosci       Date:  2018-02-23       Impact factor: 5.639

Review 7.  Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar.

Authors:  Qi-Ming Pang; Si-Yu Chen; Qi-Jing Xu; Sheng-Ping Fu; Yi-Chun Yang; Wang-Hui Zou; Meng Zhang; Juan Liu; Wei-Hong Wan; Jia-Chen Peng; Tao Zhang
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

8.  L-Arginine Depletion Improves Spinal Cord Injury via Immunomodulation and Nitric Oxide Reduction.

Authors:  Céline Erens; Jana Van Broeckhoven; Cindy Hoeks; Gernot Schabbauer; Paul N Cheng; Li Chen; Niels Hellings; Bieke Broux; Stefanie Lemmens; Sven Hendrix
Journal:  Biomedicines       Date:  2022-01-18

9.  Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway.

Authors:  Tianyu Sun; Liying Duan; Jiaju Li; Hongyu Guo; Mingyue Xiong
Journal:  Int J Mol Med       Date:  2021-06-16       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.